Table 1 Inclusion, exclusion criteria and termination criteria

Inclusion criteria

 1. Meet the diagnostic criteria for stroke (including cerebral hemorrhage and cerebral infarction) formulated by the 4th National Cerebrovascular Disease Conference in 1995and confirmed by head CT or MRI, and the course of the stroke is 1 to 6 months

 2. Abnormal hand function after stroke, Brunnstrom stage I-III, upper limb FMA-UE score lower than 47

 3. The contralateral hand is in good condition

 4. The age of the patient is 20-80 years old, and the gender is not limited

 5. No progressive stroke performance, stable vital signs

 6. Cognitive function is relatively intact, MMSE>17 or MoCA>24

 7. Be able to follow the clinical treatment plan and sign the subject's informed consent

Exclusion criteria

 1. Subjects with upper limb dysfunction before stroke

 2. Subjects with visual impairment or unilateral neglect

 3. Severe cognitive impairment or poststroke depression

 4. Metal implants in the body, such as cardiac pacemakers and other metal devices

 5. Suffering from serious underlying diseases, such as heart function level 4 (NYHA) or severe COPD

 6. Subjects participating in other clinical trials at the same time

 7. Subjects judged to be unsuitable for this trial, and withdrawing voluntarily

 8. Subjects unable to undergo MRI scans

Termination criteria

 1. Subjects have serious adverse events or adverse reactions

 2. Subjects have other changes in their condition and cannot continue the trial

 3. Subjects have significant problems in the design of the protocol or the trial and are unable to determine the efficacy